| Expression of p53, p21WAF1/CIP1, p16INK4A and Ki-67 proteins in serous ovarian tumors LG Buchynska, IP Nesina, NP Yurchenko, OO Bilyk, VN Grinkevych, ... Experimental oncology, 2007 | 64 | 2007 |
| Hepatitis C virus core protein transforms murine fibroblasts by promoting genomic instability IS Smirnova, ND Aksenov, EV Kashuba, P Payakurel, VV Grabovetsky, ... Analytical Cellular Pathology 28 (4), 177-190, 2006 | 43 | 2006 |
| GSM 900 MHz cellular phone radiation can either stimulate or depress early embryogenesis in Japanese quails depending on the duration of exposure O Tsybulin, E Sidorik, O Brieieva, L Buchynska, S Kyrylenko, D Henshel, ... International journal of radiation biology 89 (9), 756-763, 2013 | 42 | 2013 |
| Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells SV Chekhun, NY Lukyanova, YV Shvets, AP Burlaka, LG Buchynska Experimental oncology 36 (3), 179-183, 2014 | 38 | 2014 |
| Expression of the cell cycle regulators p53, p21 (WAF1/CIP1) and p16 (INK4a) in human endometrial adenocarcinoma. LG Buchynska, IP Nesina Experimental Oncology 28 (2), 152-155, 2006 | 34 | 2006 |
| Analysis of P53, P16INK4A, PRB and cyclin D1 expression and human papillomavirus in primary ovarian serous carcinoma OO Bilyk, NT Pande, LG Buchynska Experimental oncology 33 (3), 150-156, 2011 | 33 | 2011 |
| Expression of the estrogen and progesterone receptors as prognostic factor in serous ovarian cancers LG Buchynska, NP Iurchenko, VM Grinkevych, IP Nesina, SV Chekhun, ... Experimental oncology 31 (1), 48-52, 2009 | 32 | 2009 |
| Mitochondrial ribosomal protein S18-2 is highly expressed in endometrial cancers along with free E2F1 M Mints, M Mushtaq, N Iurchenko, L Kovalevska, MC Stip, D Budnikova, ... Oncotarget 7 (16), 22150-22158, 2016 | 29 | 2016 |
| Цитоморфология и цитогенетика железистой гиперплазии и рака эндометрия КП Ганина, ЛМ Полищук, ЛГ Бучинская Киев, Наукова думка, 156 с., 1990 | 29* | 1990 |
| Different trends of p53, MDM2 and p14 ARF expression patterns in endometrial adenocarcinomas versus hyperplasia. LG Buchynska, IP Nesina, EV Kashuba Experimental oncology 29 (4), 287-294, 2007 | 27 | 2007 |
| Oxidative and mutagenic effects of low intensity GSM 1800 MHz microwave radiation I Yakymenko, A Burlaka, A Tsybulin, O Brieieva, L Buchynska, ... Experimental Oncology 40 (4), 303-308, 2018 | 25 | 2018 |
| DNA repair deficiency in peripheral blood lymphocytes of endometrial cancer patients with a family history of cancer L Buchynska, O Brieieva, N Glushchenko, L Vorobyova, O Bilyk BMC cancer 14, 1-6, 2014 | 25 | 2014 |
| The frequency of human papilloma virus types 16, 18 in upper genital tract of women at high risk of developing ovarian cancer OO Bilyk, NT Pande, T Pejovic, LG Buchynska Experimental oncology 36 (2), 121-124, 2014 | 19 | 2014 |
| Markers of the epithelial-mesenchymal transition in cells of endometrial carcinoma IP Nesina, NP Iurchenko, LG Buchynska Experimental oncology 40 (3), 218-222, 2018 | 17 | 2018 |
| Assessment of HER-2/neu, с-MYC and CCNE1 gene copy number variations and protein expression in endometrial carcinomas LG Buchynska, OV Brieiev, NP Iurchenko Experimental Oncology 41 (2), 138-143, 2019 | 16 | 2019 |
| Генетическая медицина ВН Запорожан, ВА Кордюм, ЮИ Бажора, ВИ Кресюн, ИМ Трахтенберг, ... ОНМедУ, 2008 | 16 | 2008 |
| Comprehensive analysis of intratumoral lymphocytes and FOXP3 expression in tumor cells of endometrial cancer NP Iurchenko, NM Glushchenko, LG Buchynska Experimental oncology 36 (4), 262-266, 2014 | 15 | 2014 |
| Районы ядрышкового организатора в клетках эндометрия при железистой гиперплазии и раке ЛГ Бучинская, ЛЗ Полищук Экспериментальная онкология 23 (9), 157-160, 2001 | 15 | 2001 |
| FOXP3 gene promoter methylation in endometrial cancer cells LG Buchynska, NP Iurchenko, NP Verko, KA Nekrasov, VI Kashuba Experimental oncology 37 (4), 246-249, 2015 | 13 | 2015 |
| Immunofluorescence staining of paraffin sections: Creating DAB staining like virtual digital images using CMYK color conversion L Buchynska, E Kashuba, L Szekely Experimental oncology 30 (4), 327-329, 2008 | 12 | 2008 |
